Email this article to a friend

Increased bleeding risk associated with the use of recombinant human activated protein C in patients with advanced liver disease

Adam Keene*, Thomas Kawano, Syed Anees and Julie Chen

Critical Care 2008, 12:405 doi:10.1186/cc6774

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive Critical Care's emails?